Subscribe
istock-104821184
Chris Ryan / iStockphoto.com
13 November 2017Americas

Five testimonies from the Allergan-tribe patent hearing

On November 7, the House Judiciary Committee’s subcommittee on IP took part in the “ Sovereign Immunity and the Intellectual Property System” hearing.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Miami police officers sue Allergan over tribe patent deal
30 November 2017   A group of Miami police officers has filed a competition lawsuit on behalf of “potentially millions” of consumers over Allergan’s $13.75 million patent deal with the Saint Regis Mohawk Tribe.
Americas
Sovereign immunity can create uneven playing field: Goodlatte
9 November 2017   Sovereign immunity has been used to harm the IP system in recent years, according to Bob Goodlatte, chairman of the House Judiciary Committee.
Americas
Congress sets date for hearing on Allergan-tribe deal
6 November 2017   A US House of Representatives committee has called a hearing on the issue of IP rights being owned by entities that claim sovereign immunity.


Editor's picks

Explainer: ARIPO’s role in Plant Variety Protection
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025

Editor's picks

Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025

More on this story

Americas
Miami police officers sue Allergan over tribe patent deal
30 November 2017   A group of Miami police officers has filed a competition lawsuit on behalf of “potentially millions” of consumers over Allergan’s $13.75 million patent deal with the Saint Regis Mohawk Tribe.
Americas
Sovereign immunity can create uneven playing field: Goodlatte
9 November 2017   Sovereign immunity has been used to harm the IP system in recent years, according to Bob Goodlatte, chairman of the House Judiciary Committee.
Americas
Congress sets date for hearing on Allergan-tribe deal
6 November 2017   A US House of Representatives committee has called a hearing on the issue of IP rights being owned by entities that claim sovereign immunity.

More on this story

Americas
Miami police officers sue Allergan over tribe patent deal
30 November 2017   A group of Miami police officers has filed a competition lawsuit on behalf of “potentially millions” of consumers over Allergan’s $13.75 million patent deal with the Saint Regis Mohawk Tribe.
Americas
Sovereign immunity can create uneven playing field: Goodlatte
9 November 2017   Sovereign immunity has been used to harm the IP system in recent years, according to Bob Goodlatte, chairman of the House Judiciary Committee.
Americas
Congress sets date for hearing on Allergan-tribe deal
6 November 2017   A US House of Representatives committee has called a hearing on the issue of IP rights being owned by entities that claim sovereign immunity.

More features

In-house with Bayer: ‘Focus on quality early and stay close to inventors’
Explainer: ARIPO’s role in Plant Variety Protection
J&J sues over schizophrenia drug generic following patent victory
WATCH: The transparency tightrope—balancing innovation, regulation, and IP protection in a new era
Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’
Powell Gilbert launches Düsseldorf office with leading patent litigator
Startups toolkit: Why investors want more than patents
J&J fends off generic schizophrenia drug bids